News

Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials

Read article

Related Articles

News

Gameto Announces Landmark Pregnancy Rate for iPSC-Derived Fertilo, Achieving More Than Double the Success Rate of Standard IVM

News

Gameto Named as 2023 Technology Pioneer by World Economic Forum

News

Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine